Embracing Future Holdings Limited

Embracing Future Holdings Limited

SSGX:8YY
0.02
SGD
+0.00
(-4.55%)
38.89MMarket Cap
Feb 26Next Earn
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
0.01
0.01
0.01
0.01
0.03
0.01
0.01
- -
- -
- -
- -
Basic EPS, GAAP
-0.03
-0.03
-0.03
-0.05
-0.02
-0.02
-0.02
-0.03
- -
- -
- -
- -
Free Cash Flow per Basic Share
-0.02
-0.02
-0.02
-0.04
-0.02
-0.01
-0.02
-0.01
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.04
-0.07
-0.09
0.05
0.03
0.03
0.01
- -
- -
- -
- -
- -
Tangible Book Value per Share
-0.04
-0.07
-0.1
0.05
0.03
0.01
-0.01
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
256
256
256
133
256
272
265
282
593
981
1,712
1,192
Sales/Revenue/Turnover
1
2
2
1
1
9
2
2
- -
1
5
- -
Operating Margin (%)
-217.15
-82
-82.36
-381.47
-162.77
-6.49
-143.13
-121.94
-359.57
-217.09
-59.99
- -
Depreciation Expense
- -
1
1
- -
1
1
1
1
- -
- -
- -
- -
Net Income, GAAP
-8
-7
-7
-6
-5
-5
-6
-9
-2
-3
-4
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-999.12
-353.48
-346.17
-493.06
-334.45
-52.21
-258.6
-376.62
-898.19
-438.01
-75.34
- -
Working Capital
-2
-2
-7
12
6
11
4
- -
-1
-1
- -
-1
LT Debt
- -
6
6
- -
- -
4
3
2
1
1
2
2
Total Equity
-10
-17
-24
13
8
8
2
-2
-2
2
2
1
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
-47.33
-58
-112.86
- -
- -
- -
-243.14
- -

Capital Structure

SGD

•

in mil. unless spec.
Sep'24
Dec'24
Jun'25
ST Debt
2
1
1
LT Borrowings
- -
1
2
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
745
1,691
1,691
Market Capitalization
7
49
39

Working Capital

SGD

•

in mil. unless spec.
Sep'24
Dec'24
Jun'25
Total Current Assets
- -
1
1
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
3
2
1
Payables & Accruals
- -
- -
- -
ST Debt
2
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

SGD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-50.09%
-85.23%
-12.7%
Free Cash Flow
-8%
-12.59%
-84.48%
Net Income, GAAP
1.62%
13.05%
15.38%
Sales/Revenue/Turnover
124.11%
119.7%
570.79%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
1
2025
- -
4
5
2026
- -
- -
- -

Semi-annual Earnings Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Semi-annual Dividends Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Hua Zhu
Full Time Employees
16
Sector
Health technology
Industry
Biotechnology
Address
122 Emerald Hill Singapore CE Singapore 229405
IPO Date
Dec 19, 2018
Business
Embracing Future Holdings Limited, incorporated in Singapore in 2009 and formerly known as Biolidics Limited until its renaming in June 2025, is a precision medicine medical technology and diversified investment holding company. The company develops and commercializes diagnostic solutions with a focus on cell enrichment systems used in cancer diagnostics, prognosis, treatment selection, and treatment monitoring. Its core products include the ClearCell® FX1 System, a fully automated in vitro diagnostic medical device that isolates and enriches cancer cells from blood samples. The company operates multiple business segments including cancer diagnostics, infectious diseases, laboratory services with regulatory approval for COVID-19 testing in Singapore, and corporate investment activities. In recent years, Embracing Future Holdings has expanded its business scope to include technology-enabled lifestyle businesses such as multi-channel network (MCN) operations, live streaming social e-commerce platforms, and esports-related activities including game promotion and online event services. Further diversification includes strategic entry into green energy sectors focusing on renewable and sustainable energy sources like solar, wind, hydrogen, bioenergy, energy storage, and smart grid technologies, as well as artificial intelligence agent technologies leveraging generative AI, natural language processing, and machine learning for automation and digital transformation. Major recent developments include the acquisition of Shenzhen Xiaozhao Network Technology Co., Ltd in China to boost its esports marketing and services segment, establishment of subsidiaries Embracing Future E-Sports Pte. Ltd and Embracing Future MCN Pte. Ltd in 2024, and an active pursuit of strategic partnerships, joint ventures, and potential fundraising to strengthen and diversify its revenue base. The company operates primarily in Singapore, Japan, and Hong Kong with a growing presence in the Chinese market through its acquisitions and new business ventures. It targets healthcare providers, research institutions, digital content consumers, esports audiences, and renewable energy markets. Embracing Future Holdings positions itself at the intersection of healthcare technology, digital media, esports, environmental sustainability, and AI, reflecting a strategic pivot towards high-growth emerging industries while maintaining its foundation in precision medical technology and laboratory services. Its headquarters remain at Novelty BizCentre, Singapore.